Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJCV1 vaccine for Campylobacter infection
NCT02067676Phase 1Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of CJCV1 in campylobacteriosis, sponsored by U.S. Army Medical Research and Development Command. Started Apr 2014; status: completed.
02
Drugs
CJCV1
03
Conditions
campylobacteriosis
Beyond the preview
Go deeper on NCT02067676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02067676.